Despite the resurgent virus in developing economies, developed countries are making solid vaccine strides, via Goldman: Vaccinations outperformed our forecasts across all DMs in April apart from theUS. Supply will accelerate further in May, largely thanks to Pfizer-BioNTech, but also increasing capacity from other producers, and Novavax approval in the UK. The daily pace of
The post Developed economy vaccines hurtle towards travel reopening appeared first on MacroBusiness.
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]